191 related articles for article (PubMed ID: 19910560)
1. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.
Schilte MN; Celie JW; Wee PM; Beelen RH; van den Born J
Perit Dial Int; 2009; 29(6):605-17. PubMed ID: 19910560
[TBL] [Abstract][Full Text] [Related]
2. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
4. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
5. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
Mortier S; De Vriese AS; Lameire N
Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and growth factors involved in peritoneal fibrosis of peritoneal dialysis patients.
Oh KH; Margetts PJ
Int J Artif Organs; 2005 Feb; 28(2):129-34. PubMed ID: 15770592
[TBL] [Abstract][Full Text] [Related]
7. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.
Fusshoeller A
Pediatr Nephrol; 2008 Jan; 23(1):19-25. PubMed ID: 17638023
[TBL] [Abstract][Full Text] [Related]
8. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
9. Long-term intervention with heparins in a rat model of peritoneal dialysis.
Schilte MN; Loureiro J; Keuning ED; ter Wee PM; Celie JW; Beelen RH; van den Born J
Perit Dial Int; 2009; 29(1):26-35. PubMed ID: 19164250
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic targets and peritoneal membrane remodeling.
Farhat K; Stavenuiter AW; Beelen RH; Ter Wee PM
Perit Dial Int; 2014; 34(1):114-23. PubMed ID: 24525599
[TBL] [Abstract][Full Text] [Related]
11. Basic mechanisms and clinical implications of peritoneal fibrosis.
Margetts PJ; Bonniaud P
Perit Dial Int; 2003; 23(6):530-41. PubMed ID: 14703193
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.
Plum J; Hermann S; Fusshöller A; Schoenicke G; Donner A; Röhrborn A; Grabensee B
Kidney Int Suppl; 2001 Feb; 78():S42-7. PubMed ID: 11168981
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in peritoneal dialysis.
Stavenuiter AW; Schilte MN; Ter Wee PM; Beelen RH
Kidney Blood Press Res; 2011; 34(4):245-52. PubMed ID: 21691127
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
16. [Peritoneum as a dialysis membrane. II. Pathology].
Grzybowski A; Breborowicz A
Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal fibrosing syndrome: pathogenetic mechanism and current therapeutic strategies.
Hung KY; Huang JW; Tsai TJ; Hsieh BS
J Chin Med Assoc; 2005 Sep; 68(9):401-5. PubMed ID: 16187595
[TBL] [Abstract][Full Text] [Related]
18. Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model.
Stavenuiter AW; Farhat K; Schilte MN; Ter Wee PM; Beelen RH
Int J Nephrol; 2011; 2011():742196. PubMed ID: 21826269
[TBL] [Abstract][Full Text] [Related]
19. IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway.
Xiao J; Gong Y; Chen Y; Yu D; Wang X; Zhang X; Dou Y; Liu D; Cheng G; Lu S; Yuan W; Li Y; Zhao Z
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F310-F318. PubMed ID: 28490530
[TBL] [Abstract][Full Text] [Related]
20. [Anatomic-functional correlation of the peritoneal membrane].
del Peso G; Jiménez-Hefferman JA; Bajo MA; Sánchez-Villanueva R; Tabernero A; Aroeira L; Selgas R
Nefrologia; 2008; 28 Suppl 6():11-6. PubMed ID: 18957006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
